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success of endovascular procedure is achieved when TICI 2B or 3 reperfusion is obtained. 4 However, it has been shown that patients with TICI 2B reperfusion had a poorer outcome than patients with complete (TICI 3) reperfusion. 5, 6 Thus, recent studies have proposed to add mTICI 2C (nearcomplete perfusion except for slow flow in a few distal cortical vessels or presence of small distal cortical emboli 7 ) as a new reperfusion grade. Indeed, patients achieving this grade may have better functional outcomes than those achieving TICI 2B reperfusion and may resemble the clinical course of patients with TICI 3 reperfusion. [7] [8] [9] [10] However, this grade has only been evaluated in retrospective monocentric series, with a limited number of patients.
The aim of our study was to determine how much functional outcome differed between patients achieving TICI 2B, 2C, and 3 reperfusion in a large prospective multicenter cohort extracted from the ASTER randomized trial (Contact Aspiration Versus Stent Retriever for Successful Revascularization).
Materials and Methods
Inclusion Criteria
Data were extracted from the ASTER study, which was a randomized, multicenter, open-label, blinded end point clinical trial, designed to compare the effect of 2 first-line strategies for MT (contact aspiration [CA] versus stent retriever [SR]) on reperfusion rates at the end of endovascular procedures. 11 Institutional review board approval and written informed consent were obtained. The authors declare that all supporting data are available within the article.
Patients with suspected ischemic stroke secondary to occlusion of the anterior circulation within 6 hours of onset of symptoms were recruited at 8 high-volume, comprehensive stroke centers in France. Patients were required to have imaging evidence of occlusion of the intracranial internal carotid artery or the M1 or M2 branches of the middle cerebral artery. Use of intravenous thrombolysis treatment was allowed. Exclusion criteria for the present study included failure of catheterization or reperfusion (mTICI <2B), patients with spontaneous reperfusion at the beginning of the procedure, and a prestroke modified Rankin Scale (mRS) score of >3.
Patient Characteristics
Patient demographics, vascular risk factors, imaging findings, vital signs before treatment, severity of ischemic stroke, and clinical outcomes were collected prospectively with a structured questionnaire. Age, sex, cardiovascular risk factors (hypertension, dyslipidemia, diabetes mellitus, and smoking habits), time of symptom onset, National Institutes of Health Stroke Scale (NIHSS) at baseline and day 1, use of intravenous thrombolysis, and its time from symptom onset were collected. The Alberta Stroke Program Early CT Score on diffusion-weighted magnetic resonance imaging was assessed by a neuroradiologist blinded to the results of the endovascular procedure. After an in-hospital work-up, stroke cause was defined, according to the TOAST (Trial of ORG 10172 in Acute Stroke Treatment) classification.
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Endovascular Procedure
Patients were treated either with CA or an SR as the first-line intervention. The choice of anesthesia technique (conscious sedation or general anesthesia [at the beginning of the procedure or conversion]) was left at the discretion of the operator. In the ASTER trial, patients were randomly allocated in a 1:1 fashion to undergo 1 of the 2 techniques as the first-line intervention, immediately after baseline brain imaging. Both CA and SR techniques have been described previously.
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Reperfusion results were reported by using the mTICI score. 3 Two independent assessors at a central imaging core laboratory (both interventional neuroradiologists not involved in patient management) determined the mTICI score and collateral status. In cases of disagreement between the 2 assessors, a centralized neurointerventionalist reviewed angiograms and decided on the primary end point value.
Collateral arterial supply was assessed using the American Society of Interventional and Therapeutic Neuroradiology/Society of Interventional Radiology grading system, which ranges from 0 to 4 (0 indicates poor collateral supply; 4, good collateral supply). 13 A favorable collateral score refers to grade 3 to 4.
Periprocedural complications (embolization in a new territory [defined as an angiographic occlusion in a previously unaffected vascular territory observed on the angiogram after clot removal], arterial dissection or perforation, vasospasm, and subarachnoid hemorrhage) were adjudicated by 3 members of the Data and Safety Monitoring Board blinded to the treatment group. 
Follow-Up and Outcome
All patients underwent cross-sectional imaging (computed tomography or magnetic resonance imaging) within a range of 18 to 24 hours after the procedure. Intracranial hemorrhage was classified according to the ECASS (European Cooperative Acute Stroke Study) criteria. 14 Patients were evaluated 24 hours after the procedure using the NIHSS, and symptomatic intracranial hemorrhage was defined as any intracerebral hemorrhage with an increase of at least 4 NIHSS points within 24 hours, or resulting in death. The mRS at 90 days was assessed by trained research nurses unaware of the study group assignments, during face-to-face interviews, or via telephone conversations with the patients, their relatives, or their general practitioners.
The primary outcome for the present ancillary study of ASTER trial was the percentage of patients with favorable outcome defined as a 90-day mRS score of 0 to 2. Secondary clinical outcomes were the degree of disability assessed by overall distribution of the 90-day mRS (shift analysis combining scores of 5 and 6), the early neurological improvement (NI) defined as an NIHSS score of 0 to 1 at 24 hours or a decrease of ≥8 points within 24 hours, 15 the mean change in NIHSS score at 24 hours, and 90-day all-cause mortality.
Statistical Analysis
All analyses were performed among patients with successful reperfusion induced by a mechanical device (at least 1 pass, and reaching at least mTICI 2B grade after all endovascular procedures). Categorical variables were expressed as frequencies and percentages and continuous variables as means (SD), or medians (interquartile range) for non-normal distribution. Normality of distributions was assessed graphically and by using the Shapiro-Wilk test. Baseline characteristics, treatment characteristics, and early complications were described and compared according to mTICI grades (2B versus 2C versus 3) and tertiles of onset-to-reperfusion time (ORT) using the χ 2 test and the Cochran-Mantel-Haenszel trend test for categorical variables and ANOVA with linear contrast for continuous variables (nonparametric for non-normal distribution). Further details concerning statistics are given in the online-only Data Supplement.
Results
Between October 2015 and October 2016, a total of 381 patients were randomized in the ASTER trial. Of these, 290 patients were eligible to be included in the present study ( Figure) . Patients not having undergone MT (n=45) or achieving unsuccessful reperfusion (mTICI 0-2a; n=46) were excluded. Of the 290 included patients, 89 (30.7%) were graded by the core laboratory with mTICI 2B, 62 (21.4%) with mTICI 2C, and 139 (47.9%) with mTICI 3 after MT. Baseline characteristics, treatment characteristics, and early complications are described according to the grade of reperfusion in Table 1 and according to tertiles of ORT in Table I in the online-only Data Supplement. Among baseline characteristics, only hypertension and coronary artery disease were significantly associated with lower reperfusion grades (P for trend<0.05; Table 1 ). The proportion of each angiographic score (mTICI 2B/2C/3) was comparable between SR and CA ( Table 1) .
Impact of Reperfusion Grade on Clinical Outcomes
As shown in Table 2 , favorable outcome (pre-specified as primary outcome of this ancillary study) did not differ significantly between the 3 reperfusion grades, with a similar positive effect of 2C (odds ratio [OR], 1.71; 95% confidence interval [CI], 0.98-3.00) and 3 (OR, 1.73; 95% CI, 0.88-3.41) grades compared with 2B grade. When 2C and 3 grades were combined, patients with 2C/3 had a significantly higher rate of favorable outcome than patients with 2B (OR, 1.72; 95% CI, 1.01-2.90; P=0.043). This difference remained significant after prespecified adjustment on baseline factors but was only borderline after additional adjustment on complications (procedure-related adverse events and parenchymal hematoma at 24 hours). On the overall distribution of mRS ( Figure I in the online-only Data Supplement), we found no significant shift in the mRS distribution in favor of the higher mTICI grades, with a prespecified adjusted OR of 1.62 (95% CI, 0.81-2.18) for 2B, 1.34 (95% CI, 0.82-2.18) for 3, and 1.43 (0.88-2.23) for 2C/3 compared with 2B grades. There was a significant difference in early NI between 2B and 2C and between 2B and 3 ( Table 2 ) which remained significant after prespecified adjustment on baseline factors and on complications (Table 2) ; similar findings were found when the 24-hour change in NIHSS was analyzed. The 2C/3 effect sizes for early NI (fully-adjusted OR) and for ∆NIHSS at 24 hours (fully-adjusted mean difference) were 2.27 (95% CI, 1.26-4.08; P=0.006) and 3.4 (95% CI, 1.4-5.4; P<0.001), respectively. Finally, a (near) complete reperfusion (ie, TICI 2C/3 combined) was associated with a lower 90-day all-cause mortality ( 
Impact of ORT on Clinical Outcomes
As shown in Table 3 When the effect of ORT on favorable outcome was analyzed by differentiating the onset-to-groin puncture and puncture-to-reperfusion times, both time periods have a significant effect. The fully-adjusted OR per SD increase in time was 0.48 (95% CI, 0.29-0.76; P=0.002) for onset-to-puncture period (SD=116 minutes) and 0.64 (95% CI, 0.45-0.90; P=0.012) for puncture-to-reperfusion period (SD=32 minutes).
Independent Effect of Reperfusion Grades and Time on Clinical Outcomes
In multivariate analysis including prespecified factors and complications, we found no significant interaction between CA indicates contact aspiration; CI, confidence interval; mRS, modified Rankin Scale; mTICI, modified Thrombolysis in Cerebral Infarction score; NIHSS, National Institutes of Health Stroke Scale; and OR, odds ratio.
*P values for comparisons between the 3 mTICI grades. †P values for trend. ‡Ninety-day mRS score of ≤2. §Adjusted for prespecified baseline factors (center, first-line CA strategy, age, hypertension, diabetes mellitus, baseline NIHSS score, and site of occlusion). ║Adjusted for prespecified baseline factors and complications (procedure-related adverse events and parenchymal hematoma). ¶NIHSS score of 0-1 at 24 hours or a decrease of ≥8 points within 24 hours. #P value for comparison with mTICI 2B score of <0.010. **P value for comparison with mTICI 2B score of <0.05. † †Seventeen missing values. ‡ ‡Adjusted on baseline NIHSS score.
mTICI 2C/3 grade and ORT on favorable outcome (P=0.82), on overall mRS distribution (P=0.66), early NI (P=0.53), 24-hour change in NIHSS (P=0.63), and mortality (P=0.99). The detrimental effect of ORT on favorable and early NI outcomes remained significant, whereas the effect of mTICI 2C/3 reached significance only for early NI and 24-hour change in NIHSS (Table II in the online-only Data Supplement).
Discussion
Our study shows that combining mTICI 2C and TICI 3 grades helps to determine a subgroup of patients who achieve better functional outcomes than mTICI 2B patients. Indeed, in our study, favorable outcome (pre-specified as primary outcome of this ancillary study) did not differ significantly between the 3 reperfusion grades. However, when 2C and 3 grades were combined, we observed that patients with 2C/3 had higher rates of favorable outcome than patients with 2B reperfusion.
Our findings are in line with those of Tung et al, 8 who observed a significant difference in early NI and functional outcomes between mTICI 2C and both mTICI 2C and TICI 3 patients. They are also concordant with the results observed in the first study describing the mTICI 2C grade, where authors observed improved clinical outcomes as evaluated by the change in NIHSS at 24 hours and 90-day mRS with mTICI 2C and TICI 3 patients compared with TICI 2B patients. Of note, the original definition of TICI 2B (>1/3 reperfusion) was used in this article. 7 We chose to use the modified definition of the TICI 2B score, introduced by the IMS investigators because it is simpler and shows better interrater agreement than the original definition. 16 Our study is, however, the first to assess the usefulness of mTICI 2C/3 grades for stroke prognosis prediction using data from a randomized controlled trial. 11 As a consequence, our results show that mTICI 2C/3 angiographic outcome is achievable in a high proportion of patients with both MT techniques (CA and SR) with ≤3 passes in most cases. Moreover, the use of an external core laboratory for angiographic outcome adjudication ensures that TICI interpretation was not prone to subjective interpretation biases by the operators. Our results also complement our previous ones on the differences in functional outcomes between mTICI 2B and TICI 3 patients. Indeed, 1 limit of our previous study was that we did not consider mTICI 2C reperfusion grade. 6 
Impact of Reperfusion Grade on Clinical Outcomes
Although favorable functional outcome did not differ significantly between the 3 reperfusion grades, we observed more often favorable functional outcomes when patients achieving mTICI 2C and TICI 3 grades were combined. These results complement those observed in a previous study evaluating the introduction of the mTICI 2C grade, where patients achieving mTICI 2C reperfusion seemed to follow the clinical course of patients with TICI 3 reperfusion, rather than that of patients with mTICI 2B reperfusion. 7, 8, 10 Indeed, in a recent study, no difference could be noted when comparing patients with mTICI 2C and TICI 3 reperfusions on functional outcome at discharge and at 3 months. 10 In addition, occurrence of any intracranial hemorrhage was lower when the degree of perfusion increased, results that are in line with a previous study. 6 
Early NI
On early NI, our results are in accordance with those reported in a recent study evaluating differences in early NI and independence at 90 days using the original TICI, modified TICI, and modified TICI with 2C grades. 8 They are also concordant with former studies observing a strong link between early NI and arterial reperfusion.
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Impact of ORT
In our study, favorable outcome rate decreased with increasing ORT, with an OR per SD (119 minutes) increase in time of 0.58 (95% CI, 0.44-0.76). Interestingly, we found an independent effect of reperfusion grades and time on clinical outcomes, unlike a recent study showing that the effect of time could be greater in patients achieving incomplete (TICI 2A) reperfusion. 18 Of note, the effect of ORT was preponderant, with poorer outcomes with increased ORT (except 90-day mortality), whereas the effect of mTICI 2C/3 reached the significance level only for early NI and 24-hour change in NIHSS.
Limits
The mTICI 2C grade, 7 defined by near-complete perfusion except for slow flow or distal emboli in a few distal cortical vessels, may be difficult to interpret given the lack of objective parameters such as obvious arterial occlusion. Interreliability of this scale should be assessed in further studies as well. Another limit of this grade is that mTICI 2C reperfusion remains a heterogeneous group of patients with various parenchymal defects regardless of their clinical significance.
We did not dichotomize final mTICI 2C/3 reperfusions as direct (reperfusion before final maneuver ≤TICI 2a) or secondarily improved (mTICI 2B was first achieved). However, a recent study showed that outcome of patients with direct or secondarily improved mTICI 2C/3 did not differ, although procedure time was higher in the secondarily improved mTICI 2C/3 group when compared with the direct mTICI 2C/3 group. 10 Finally, we did not study other potential relationships between angiographic outcome at the end of the procedure and follow-up imaging parameters such as the final infarct volume.
Conclusions
Combining mTICI 2C and TICI 3 grades helps to determine a subgroup of patients who achieve better functional outcomes than mTICI 2B patients. Achieving the mTICI 2C/3 reperfusion grade rather than mTICI 2B/3 should be the interventionalist's goal in endovascular stroke treatment for anterior circulation LVO.
